Incretin hormones, along with the chemically similar GLP-1 receptor agonists, slow gut motility and, therefore, slow the emptying of the gastrointestinal tract
It's not a switch you flip
Non-Alcoholic fatty liver disease, liver fibrosis, and regional Amyloid- and Tau pathology in Middle-Aged adults: the Framingham study
By combining three receptor pathways , Retatrutide isnt just another hunger suppressant its a new class of peptide therapy that attacks fat loss from multiple metabolic angles , potentially setting a new standard for clinical and performance-based body recomposition
And yet, your eating habits havent changed
(Take note: we adhere to integrative functional medicine in Toronto, which is why each patient is treated as a unique entity